KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Intangibles (2022 - 2025)

Historic Intangibles for Halozyme Therapeutics (HALO) over the last 4 years, with Q4 2025 value amounting to $981.5 million.

  • Halozyme Therapeutics' Intangibles rose 14424.93% to $981.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $981.5 million, marking a year-over-year increase of 14424.93%. This contributed to the annual value of $981.5 million for FY2025, which is 14424.93% up from last year.
  • Latest data reveals that Halozyme Therapeutics reported Intangibles of $981.5 million as of Q4 2025, which was up 14424.93% from $348.5 million recorded in Q3 2025.
  • Halozyme Therapeutics' 5-year Intangibles high stood at $981.5 million for Q4 2025, and its period low was $348.5 million during Q3 2025.
  • In the last 4 years, Halozyme Therapeutics' Intangibles had a median value of $472.9 million in 2023 and averaged $551.3 million.
  • Per our database at Business Quant, Halozyme Therapeutics' Intangibles crashed by 4829.39% in 2023 and then surged by 14424.93% in 2025.
  • Over the past 4 years, Halozyme Therapeutics' Intangibles (Quarter) stood at $546.7 million in 2022, then dropped by 13.5% to $472.9 million in 2023, then fell by 15.02% to $401.8 million in 2024, then soared by 144.25% to $981.5 million in 2025.
  • Its Intangibles was $981.5 million in Q4 2025, compared to $348.5 million in Q3 2025 and $366.3 million in Q2 2025.